Analyst Price Targets — BF-A
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 9, 2026 1:31 pm | Nadine Sarwat | Bernstein | $29.00 | $26.72 | StreetInsider | Bernstein SocGen Group Reiterates Market Perform Rating on Brown Forman (BF-B) |
| June 8, 2026 6:55 am | — | UBS | $28.00 | $26.69 | StreetInsider | BofA Securities Upgrades Brown Forman (BF-B) to Neutral |
| December 2, 2025 1:48 pm | Nik Modi | RBC Capital | $30.00 | $29.01 | StreetInsider | RBC Capital Reiterates Sector Perform Rating on Brown Forman (BF-B) |
Latest News for BF-A
LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE: BFA, BFB) announced today that President and Chief Executive Officer Lawson Whiting and Executive Vice President and Chief Financial Officer Jim Peters will participate in a “fireside chat” during the Barclays Global Consumer Conference in Boston on Wednesday, September 9, 2026. The event will begin at approximately 12:45 p.m. (EDT) and will be…
BF.B heads into Q1 with premiumization and brand investments facing muted demand, portfolio headwinds and an uncertain earnings setup.
Brown-Forman B (BF.B) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The heirs to one of America's biggest liquor fortunes are in the middle of an intense family drama. Profits at Brown-Forman are shrinking, and shares in the spirits company have lost 60% of their value over five years.
About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays, arguing that boring income names carried real upside if the market ever noticed.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BF-A.
U.S. House Trading
No House trades found for BF-A.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.